Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: Proceed with caution

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 379-

  Bombard, Allan T ^a   Farkas, Daniel H ^a   Monroe, Thomas J ^a   Saldivar, Juan Sebastian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME DELETION; FEMALE; HUMAN; INDEL MUTATION; LETTER; MICROARRAY ANALYSIS; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRISOMY; TRISOMY 16; TRISOMY 21;

EID: 84904974006     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000400     Document Type: Letter

References (4)

1. Vora NL, O'Brien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014;123:1097-99.
2. College of American Pathologists. Molecular pathology checklist. Available at: www.CAP.org. Retrieved May 28, 2014.
3. Centers for Disease Control and Prevention. Clinical laboratory improvement amendments. Available at: http://wwwn. cdc.gov/CLIA/Default.aspx. Retrieved May 28, 2014.
4. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-74.